correlational
Analysis v1
32
0
When liver transplant patients with fatty liver disease had lower levels of a liver enzyme called alkaline phosphatase after treatment, their liver fat also tended to decrease more. This finding is from the abstract summary - full study details were not available
Scientific Claim
Reduction in serum alkaline phosphatase levels was associated with a positive response in liver fat reduction (MRI-PDFF) in liver transplant recipients with NAFLD treated with saroglitazar.
Original Statement
“Reduction in serum alkaline phosphatase was an independent predictor of MRI-PDFF response.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study design allows for observing correlations between variables, and the language used matches the evidence.
Evidence from Studies
Supporting (1)
32
32
Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients
Cross-Sectional Study
Human
2023 Sep 1Contradicting (0)
0
No contradicting evidence found